Incidência e mortalidade de leucemias e linfomas infantojuvenil em Mato Grosso
##plugins.themes.bootstrap3.article.sidebar##
Publicado
Jul 27, 2024
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: analisar a tendência de incidência e mortalidade de leucemias e linfomas infantojuvenil, bem como estimar a sobrevida por meio da razão de mortalidade/incidência em Mato Grosso. Métodos: foram analisados dados do registro de câncer de base populacional de Mato Grosso de 2001 a 2017, e dados de mortalidade de 2001 a 2021 extraídos do Sistema de Informação sobre Mortalidade. A análise consistiu em frequências, taxas de incidência ajustadas (TxA) por milhão e resultados da regressão de joinpoint. Estimativas de sobrevida foram calculadas por meio da razão de números de óbitos e de casos incidentes [1-(M:I)] de 2013 a 2017. Resultados: as leucemias representaram 67,7 % dos casos com uma TxA de incidência 29,9 e de 13,9 para os linfomas e a taxa de mortalidade, foi 18,0. Observou-se tendência de redução significativa na incidência de leucemias em ambos os sexos -4,0% e no sexo feminino -5,5%, enquanto a incidência de linfomas e a mortalidade permaneceram estáveis. As estimativas de sobrevida foram de 88% e 74% para leucemias e linfomas. Conclusão: as taxas de incidência, mortalidade e as estimativas de sobrevida foram intermediárias a contextos epidemiológicos de países de alta e média renda, apresentando redução significativa na incidência de leucemias.
##plugins.themes.bootstrap3.article.details##
Como Citar
SouzaP. C. F. de, EspinosaM. M., TeixeiraM. T. B., LimaF. C. da S. de, & GalvãoN. D. (2024). Incidência e mortalidade de leucemias e linfomas infantojuvenil em Mato Grosso. Revista Eletrônica Acervo Saúde, 24(7), e16906. https://doi.org/10.25248/reas.e16906.2024
Seção
Artigos Originais
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1 ALLEMANI C, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet, 2018; 391 (10125): 1023-1075.
2 ASADZADEH VOSTAKOLAEI F, et al. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. The European Journal of Public Health, 2011; 21 (5): 573-577.
3 BERTUCCIO P, et al. Childhood cancer mortality trends in Europe, 1990-2017, with focus on geographic differences. Cancer epidemiology, 2020; (67): 101768.
4 BHAKTA N, et al. Childhood cancer burden: a review of global estimates. The lancet oncology, 2019; 20 (1): e 42-e53.
5 BRASIL. Instituto Nacional do Câncer José Alencar Gomes da Silva INCA. Estimativa 2023: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2022.
6 BRASIL. Ministério da Saúde. Sistema de Informações em saúde - DATASUS. 2021. Disponível em: https://datasus.saude.gov.br/informacoes-de-saude-tabnet/. Acesso em: 03 ago. 2021.
7 CAMARGO B, et al. Cancer incidence among children and adolescents in Brazil: First report of 14 population‐based cancer registries. International journal of cancer, 2010; 126 (3): 715-720.
8 CHATENOUD L, et al. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer, 2010; 116 (21): 5063-5074.
9 CLEGG LX, et al. Estimating average annual per cent change in trend analysis. Statistics in medicine, 2009; 28 (29): 3670-3682.
10 COOK MB, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiology Biomarkers & Prevention, 2009; 18 (4): 1174-1182.
11 CURADO MP, et al. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Revista Panamericana de Salud Pública, 2011; 29 (2): 96-102.
12 DOLL R, et al. (Ed.). Cancer Incidence in Five Continents: Volume II–1970. Springer Science & Business Media; 2012.
13 FELICIANO SVM, et al. Incidence and mortality of myeloid malignancies in children, adolescents and Young adults in Brazil: A population-based study. Cancer Epidemiology, 2019; (62): 101583.
14 FERMAN S, et al. Childhood cancer mortality trends in Brazil, 1979–2008. Clinics, 2013; 68 (2): 219-224.
15 FERREIRA JMO, et al. Lymphoma subtype incidence rates in children and adolescents: first report from Brazil. Cancer epidemiology, 2012; 36 (4): e221-e226.
16 FIDLER MM, et al. Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ, 2016; 354.
17 FORCE LM, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. The Lancet Oncology, 2019; 20 (9): 1211-1225.
18 GOUJON S, et al. Spatial and temporal variations of childhood cancers: literature review and contribution of the French national registry. Cancer medicine. 2018; 7(10): 5299-5314.
19 GUPTA S, et al. Treating childhood cancer in low-and middle-income countries. Cancer. Washington DC: The World Bank Group, 2015; 121-46.
20 HOWARD SC, et al. The My Child Matters programme: effect of public–private partnerships on paediatric cancer care in low-income and middle-income countries. The Lancet Oncology, 2018; 19 (5): e252-e266.
21 JOHNSTON WT, et al. Childhood cancer: Estimating regional and global incidence. Cancer epidemiology, 2021; (71): 101662.
22 KAATSCH P. Epidemiology of childhood cancer. Cancer treatment reviews, 2010; 36 (4): 277-285.
23 KARIM-KOS HE, et al. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994 2011. Cancer epidemiology, 2016; 42: 72-81.
24 KIM HJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine, 2000; 19 (3): 335-351.
25 MARCOS-GRAGERA R, et al. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clinical and Translational Oncology, 2018; (20): 1289-1301.
26 PARKIN DM e BRAY F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European journal of cancer, 2009; 45 (5): 756-764.
27 REULEN RC, et al. Long-term cause-specific mortality among survivors of childhood cancer. Jama, 2010; 304 (2): 172-179.
28 SIEGEL DA, et al. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. JNCI: Journal of the National Cancer Institute, 2023; 115 (11): 1337-1354.
29 SILVA NP, et al. Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Revista Panamericana de Salud Pública, 2024; 48: e11.
30 STELIAROVA‐FOUCHER E, et al. International classification of childhood cancer. Cancer, 2005; 103 (7): 1457-1467.
31 STELIAROVA-FOUCHER E, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. The Lancet Oncology, 2017; 18 (6): 719-731.
32 STELIAROVA-FOUCHER E, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study. The Lancet Oncology, 2018; 19 (9): 1159-1169.
33 SUNKARA V e HÉBERT JR. The application of the mortality‐to‐incidence ratio for the evaluation of cancer care disparities globally. Cancer, 2016; 22 (3): 487-488.
34 TRALLERO J, et al. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018. Frontiers in Oncology, 2023; (13): 1197850.
35 WARD ZJ, et al. Estimating the total incidence of global childhood cancer: a simulation-based analysis. The Lancet Oncology, 2019; 20 (4): 483-493.
36 WHO global initiative for childhood cancer: an overview. In: World Health Organization; Disponível em: https://www.who.int/docs/default-source/documents/health-topics/cancer/who-childhood-cancer-overview-booklet.pdf?sfvrsn=83cf4552_1&download=true
37 YEH JM, et al. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Annals of internal medicine, 2010; 152 (7): 409-417.
38 YOULDEN DR, et al. The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035. Medical Journal of Australia, 2020; 212 (3): 113-120.
2 ASADZADEH VOSTAKOLAEI F, et al. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. The European Journal of Public Health, 2011; 21 (5): 573-577.
3 BERTUCCIO P, et al. Childhood cancer mortality trends in Europe, 1990-2017, with focus on geographic differences. Cancer epidemiology, 2020; (67): 101768.
4 BHAKTA N, et al. Childhood cancer burden: a review of global estimates. The lancet oncology, 2019; 20 (1): e 42-e53.
5 BRASIL. Instituto Nacional do Câncer José Alencar Gomes da Silva INCA. Estimativa 2023: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2022.
6 BRASIL. Ministério da Saúde. Sistema de Informações em saúde - DATASUS. 2021. Disponível em: https://datasus.saude.gov.br/informacoes-de-saude-tabnet/. Acesso em: 03 ago. 2021.
7 CAMARGO B, et al. Cancer incidence among children and adolescents in Brazil: First report of 14 population‐based cancer registries. International journal of cancer, 2010; 126 (3): 715-720.
8 CHATENOUD L, et al. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer, 2010; 116 (21): 5063-5074.
9 CLEGG LX, et al. Estimating average annual per cent change in trend analysis. Statistics in medicine, 2009; 28 (29): 3670-3682.
10 COOK MB, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiology Biomarkers & Prevention, 2009; 18 (4): 1174-1182.
11 CURADO MP, et al. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Revista Panamericana de Salud Pública, 2011; 29 (2): 96-102.
12 DOLL R, et al. (Ed.). Cancer Incidence in Five Continents: Volume II–1970. Springer Science & Business Media; 2012.
13 FELICIANO SVM, et al. Incidence and mortality of myeloid malignancies in children, adolescents and Young adults in Brazil: A population-based study. Cancer Epidemiology, 2019; (62): 101583.
14 FERMAN S, et al. Childhood cancer mortality trends in Brazil, 1979–2008. Clinics, 2013; 68 (2): 219-224.
15 FERREIRA JMO, et al. Lymphoma subtype incidence rates in children and adolescents: first report from Brazil. Cancer epidemiology, 2012; 36 (4): e221-e226.
16 FIDLER MM, et al. Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ, 2016; 354.
17 FORCE LM, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. The Lancet Oncology, 2019; 20 (9): 1211-1225.
18 GOUJON S, et al. Spatial and temporal variations of childhood cancers: literature review and contribution of the French national registry. Cancer medicine. 2018; 7(10): 5299-5314.
19 GUPTA S, et al. Treating childhood cancer in low-and middle-income countries. Cancer. Washington DC: The World Bank Group, 2015; 121-46.
20 HOWARD SC, et al. The My Child Matters programme: effect of public–private partnerships on paediatric cancer care in low-income and middle-income countries. The Lancet Oncology, 2018; 19 (5): e252-e266.
21 JOHNSTON WT, et al. Childhood cancer: Estimating regional and global incidence. Cancer epidemiology, 2021; (71): 101662.
22 KAATSCH P. Epidemiology of childhood cancer. Cancer treatment reviews, 2010; 36 (4): 277-285.
23 KARIM-KOS HE, et al. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994 2011. Cancer epidemiology, 2016; 42: 72-81.
24 KIM HJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine, 2000; 19 (3): 335-351.
25 MARCOS-GRAGERA R, et al. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clinical and Translational Oncology, 2018; (20): 1289-1301.
26 PARKIN DM e BRAY F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European journal of cancer, 2009; 45 (5): 756-764.
27 REULEN RC, et al. Long-term cause-specific mortality among survivors of childhood cancer. Jama, 2010; 304 (2): 172-179.
28 SIEGEL DA, et al. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. JNCI: Journal of the National Cancer Institute, 2023; 115 (11): 1337-1354.
29 SILVA NP, et al. Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Revista Panamericana de Salud Pública, 2024; 48: e11.
30 STELIAROVA‐FOUCHER E, et al. International classification of childhood cancer. Cancer, 2005; 103 (7): 1457-1467.
31 STELIAROVA-FOUCHER E, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. The Lancet Oncology, 2017; 18 (6): 719-731.
32 STELIAROVA-FOUCHER E, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study. The Lancet Oncology, 2018; 19 (9): 1159-1169.
33 SUNKARA V e HÉBERT JR. The application of the mortality‐to‐incidence ratio for the evaluation of cancer care disparities globally. Cancer, 2016; 22 (3): 487-488.
34 TRALLERO J, et al. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018. Frontiers in Oncology, 2023; (13): 1197850.
35 WARD ZJ, et al. Estimating the total incidence of global childhood cancer: a simulation-based analysis. The Lancet Oncology, 2019; 20 (4): 483-493.
36 WHO global initiative for childhood cancer: an overview. In: World Health Organization; Disponível em: https://www.who.int/docs/default-source/documents/health-topics/cancer/who-childhood-cancer-overview-booklet.pdf?sfvrsn=83cf4552_1&download=true
37 YEH JM, et al. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Annals of internal medicine, 2010; 152 (7): 409-417.
38 YOULDEN DR, et al. The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035. Medical Journal of Australia, 2020; 212 (3): 113-120.